scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1027922625 |
P356 | DOI | 10.1007/S00280-016-3202-8 |
P698 | PubMed publication ID | 27913882 |
P2093 | author name string | Seung Kew Yoon | |
Jong Young Choi | |||
Sung Won Lee | |||
Jeong Won Jang | |||
Hae Lim Lee | |||
Si Hyun Bae | |||
Nam Ik Han | |||
P2860 | cites work | Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future | Q26771776 |
Risk of tumor cell seeding through biopsy and aspiration cytology | Q26827557 | ||
Biology of hepatocellular carcinoma | Q28266656 | ||
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival | Q29616865 | ||
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial | Q29617955 | ||
Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma | Q29617957 | ||
Transarterial chemoembolization (TACE) plus sorafenib versus TACE for intermediate or advanced stage hepatocellular carcinoma: a meta-analysis | Q33778970 | ||
Lack of response after initial chemoembolization for hepatocellular carcinoma: does it predict failure of subsequent treatment? | Q34065128 | ||
Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. | Q34552875 | ||
Predictors of mortality in patients with hepatocellular carcinoma undergoing transarterial chemoembolization | Q35178251 | ||
Extrahepatic metastases occur in a minority of hepatocellular carcinoma patients treated with locoregional therapies: analyzing patterns of progression in 285 patients. | Q35877902 | ||
Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study | Q36404761 | ||
Effectiveness of Sorafenib in Patients with Transcatheter Arterial Chemoembolization (TACE) Refractory and Intermediate-Stage Hepatocellular Carcinoma | Q36423170 | ||
Modified RECIST (mRECIST) assessment for hepatocellular carcinoma | Q37696396 | ||
In intermediate stage hepatocellular carcinoma: radioembolization with yttrium 90 or chemoembolization? | Q38984450 | ||
Predictive factors for complete response of chemoembolization with drug-eluting beads (DEB-TACE) for hepatocellular carcinoma | Q41235807 | ||
DC Bead Transarterial Chemoembolization Is Effective in Hepatocellular Carcinoma Refractory to Conventional Transarteral Chemoembolization: A Pilot Study | Q42153654 | ||
A Randomized Trial Comparing Radiofrequency Ablation and Surgical Resection for HCC Conforming to the Milan Criteria | Q43484980 | ||
Radiological response predicts survival following transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma. | Q44453052 | ||
Local radiotherapy as a complement to incomplete transcatheter arterial chemoembolization in locally advanced hepatocellular carcinoma | Q44835494 | ||
Intention-to-treat analysis of liver transplantation for hepatocellular carcinoma: living versus deceased donor transplantation | Q46082144 | ||
Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma | Q48351437 | ||
Radioembolization With Yttrium-90 Resin Microspheres in Hepatocellular Carcinoma: A Multicenter Prospective Study. | Q50770174 | ||
Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma. | Q51873576 | ||
P433 | issue | 1 | |
P304 | page(s) | 81-88 | |
P577 | publication date | 2016-12-02 | |
P1433 | published in | Cancer Chemotherapy and Pharmacology | Q326137 |
P1476 | title | Early treatment response to transcatheter arterial chemoembolization is associated with time to the development of extrahepatic metastasis and overall survival in intermediate-stage hepatocellular carcinoma | |
P478 | volume | 79 |
Search more.